Single-cell technologies have revolutionized cancer research and personalized medicine, allowing for targeted therapies and characterization of the tumour microenvironment beyond what was capable via ...

Immunai, an AI biotech company specializing in mapping the human immune system, and the Parker Institute for Cancer Immunotherapy (PICI), a San Francisco-based nonprofit organization that unites ...